Drug Shortage Report for SANDOZ OLOPATADINE

Last updated on 2021-05-03 History
Report ID 138115
Drug Identification Number 02358913
Brand name SANDOZ OLOPATADINE
Common or Proper name SANDOZ OLOPATADINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) OLOPATADINE
Strength(s) 0.1%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML LDP V1 CA
ATC code S01GX
ATC description DECONGESTANTS AND ANTIALLERGICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-04-23
Estimated end date 2021-04-30
Actual end date 2021-04-30
Shortage status Resolved
Updated date 2021-05-03
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-05-03 French Compare
v3 2021-05-03 English Compare
v2 2021-04-27 French Compare
v1 2021-04-27 English Compare